Home/News/Details

EU Biocidal Products Fee Standards Increase with Inflation Pressure Driving a 19.5% Rise

Aug 6, 2025
EU
BPR
Favorite
Share
Unlock exclusive content and benefits? Sign up for free today!

On July 28, 2025, following the draft proposal to increase REACH registration fees, the European Commission passed Implementing Regulation No. 2025/1490, announcing an immediate increase in all official fees related to the approval of biocidal products. This adjustment reflects the cumulative inflation level of 19.5% between 2021 and 2023. Unlike the REACH draft, whose implementation date is yet to be determined, the new regulations for biocides will officially take effect on August 14, 2025, and will be directly applicable in all member states.

Background

In 2012, the EU issued the Biocidal Products REGULATION (EU) No 528/2012, requiring all active substances and biocidal products containing active substances to be approved or authorized before being marketed in the EU. In 2013, the accompanying Implementing Regulation (EU) No 564/2013 set detailed fee standards and introduced an annual inflation adjustment clause. This revision is the third systematic adjustment of this clause since its implementation in 2013.

Main Adjustments

  1. Active Substance Approval
    • Initial approval fee increased from €120,000 to €143,400.
    • An additional €47,800 charged for each new product type (previously €40,000).
  2. Renewal of Active Substance Approval
    • Renewal fee for the first product category increased from €15,000 to €17,925.
    • An additional €29,875 charged for a comprehensive re-evaluation (previously €25,000).
  3. EU Authorization (Single Product)
    • New product authorization fee different from the representative product increased to €95,600 (previously €80,000).
    • "Same product" authorization fee for products identical to the representative product increased to €47,800 (previously €40,000).
  4. EU Authorization (Product Family)
    • Entire product family authorization fee increased to €179,250 (previously €150,000).
  5. Annual Fees
    • Annual maintenance fee for a single product increased to €11,950 (previously €10,000).
    • Annual maintenance fee for a product family increased to €23,900 (previously €20,000).
  6. Other Items
    • Major change application fee: €47,800 (previously €40,000).
    • Minor change application fee: €17,925 (previously €15,000).
    • Administrative change notification fee: €2,390 (previously €2,000).
    • Technical equivalence determination fee: depending on complexity, €5,975 / €23,900 / €47,800.
    • Appeal fee: €2,988 (previously €2,500).

Micro, small, and medium-sized enterprises (SMEs) will continue to enjoy tiered fee reductions, with the reduction percentage based on the new standard fees, and eligibility criteria remain unchanged.

 

Further Information

ECHA

ChemRadar Copyright Disclaimers:

1. All texts, graphics, videos and audios with "Source: ChemRadar" on this website are copyrighted by ChemRadar. Without authorization, no media, website or individual is allowed to reproduce, link, distribute, publish, or copy any content in this website. Other media, website with our authorization shall indicate "Source: CIRS Group" when downloading or using relevant contents. Unauthorized actions will be persecuted.

2. Texts and graphics on thie website without "Source: ChemRadar" are reproduced for further information but not imply the endorsement of views or autheticity of its content. Other media, websites or individuals download or use relevant content shall remain its "Source" as prescribed in this website and bear corresponding legal responsibilities. Any unauthorized alternation to "Source: ChemRadar" may be persecuted. If you have any questions about relevant content on this website, please contact us.

3. If any content reproduced on ChemRadar raises copyright or other related issues, please contact us within two weeks.

Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
Feedbacks
Service Hotline